ALA Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Arovella Therapeutics Ltd

Watchlist Manager

Watchlist

Price: 0.069 AUD -2.82% Market Closed

Market Cap: AU$83.4m

	Arovella Therapeutics Ltd ASX:ALA	AU
	Zedge Inc F:34Z	US
	Cemindia Projects Ltd NSE:CEMPRO	IN
	Duratec Ltd ASX:DUR	AU
	Amcor PLC OTC:AMCCF	UK
S	Scilex Holding Co NASDAQ:SCLX	US
	Pool Corp NASDAQ:POOL	US

Profitability Summary

Arovella Therapeutics Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Sustainable 3Y Average Gross Margin

39%

Negative Operating Margin

-2 561%

Negative 3Y Average Operating Margin

-3 432%

Declining Operating Margin

-1 435% > -2 561%

Negative Net Margin

-1 415%

Negative 3Y Average Net Margin

-3 262%

Declining Net Margin

-1 285% > -1 415%

Negative Free Cash Flow Margin

-1 168%

Negative 3Y Average Free Cash Flow Margin

-2 420%

Declining Free Cash Flow Margin

-1 075% > -1 168%

Negative ROE

-52%

Negative 3Y Average ROE

Exceptional 3Y Average ROIC

2 455%

ROIC is Increasing

-697% > 8 016%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.